International Affairs Committee
From the three perspectives of international expansion, international harmonization, and contribution to global health, the International Committee deepens cooperation with regulatory authorities, pharmaceutical organizations, and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in various countries and conducts activities to resolve international issues faced by the industry and member companies.
Announcements & Updates
-
International Affairs Committee
Report on the “Side Event Held in New York, U.S., During the 81st Session of the United Nations Assembly (UNGA)”
-
Pharmaceutical Industrial Policy Committee International Affairs Committee
We have posted “On Institutional Measures to Ensure a Stable Supply of Medicines and Other Products Necessary for Infectious Disease Control and to Promote Antimicrobial Drug Discovery.”
-
International Affairs Committee
We have posted an article titled “Side Event Report — 79th World Health Assembly (WHA79)”
-
International Affairs Committee
Creating the Future of Medical Care with Asia: Japan's Contribution to the Collaboration with Bac Mai Hospital (Vietnam)
-
International Affairs Committee
Report on "The 5th Japan-Vietnam Joint Symposium" is now available.
International Affairs Committee Content
-
Implementation Plan
This year’s implementation plan is now available.
-
Global Health
Information on Global Health.
-
STOP AMR
JPMA's activities against drug resistance (AMR) are posted.
-
Statement
The JPMA’s statements are posted here.
-
DATA (Members only)
Back issues of international news and research materials are posted.
-
Announcement from International Affairs Committee
Various announcements from the International Affairs Committee are posted.
-
Action Fund for Drug Resistance (AMR)
JPMA contributes to the establishment of this fund as an IFPMA member organization and promotes advocacy.
